Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Establishment of 68Ga-DOTA-Based Pretargeted Radioimmunodiagnosis
Darren R. Veach
, Daniela Burnes Vargas
, Baharul Islam
, Sang Gyu Lee
, Leah Gajecki
, Brett A. Vaughn
, Guangbin Yang
, Teja Muralidhar Kalidindi
, Naga Vara Kishore Pillarsetty
, Niloufar Salehi
, Ambika P. Jaswal
, Sayani Saha
, Alexandre B. Le Roux
, Hong Xu
, Hong fen Guo
, Ouathek Ouerfelli
, Nai Kong V. Cheung
,
Simone Krebs
, Steven M. Larson
, Sarah M. Cheal
Nuclear Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Establishment of 68Ga-DOTA-Based Pretargeted Radioimmunodiagnosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Retargeting
100%
Radioimmunodiagnosis
100%
68Ga-DOTA
100%
NODAGA
100%
Gallium-68
80%
PET Imaging
40%
Hapten
40%
Tumor
20%
Pharmacokinetics
20%
Transmembrane
20%
In Vitro Study
20%
Antitumor
20%
Acetic Acid
20%
High Contrast
20%
Human Colorectal Cancer
20%
Tumor Uptake
20%
Reporter Gene
20%
Tumor Targeting
20%
Proteus
20%
ScFv
20%
Clinical Translation
20%
Chelator
20%
Radiochemical Purity
20%
Radiochemical Yield
20%
1,4,7,10-tetraazacyclododecane
20%
Companion Diagnostics
20%
Benzyl
20%
Antibody Recognition
20%
Embryonic Kidney
20%
Bispecific Antibody
20%
Lutetium-177 (177Lu)
20%
Radiometals
20%
Glutaric Acid
20%
1,4,7-triazacyclononane
20%
Serum Protein Binding
20%
GPA33
20%
Broad-spectrum Antibody
20%
Colorectal Cancer Models
20%
Engineered Cells
20%
293T Cells
20%
68Ga-labeling
20%
Well-matched
20%
Pretargeted Radioimmunotherapy
20%
Radiostability
20%
Pharmacology, Toxicology and Pharmaceutical Science
Tetraxetan
100%
Gallium 68
100%
Neoplasm
16%
Polyethylene Terephthalate
16%
Hapten
16%
Colorectal Carcinoma
8%
Mouse Model
8%
Pharmacokinetic
8%
Chelating Agent
8%
Yttrium 90
8%
Potassium Acetate
8%
Plasma Protein Binding
8%
Antigen
8%
Bispecific Antibody
8%
Actinium 225
8%
Lutetium 177
8%
Glutaric Acid
8%